Skip to main content
SKIN
NASDAQ Life Sciences

Q3 Sales Slip 2.1% but Adjusted EBITDA Jumps to $13.4M; Guidance Reaffirmed

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Household Product Stocks · Consumer
Sentiment info
Positive
Importance info
7
Price
$10.35
Mkt Cap
$67.348M
52W Low
$9.68
52W High
$34.8
52W Position info
6.9% above low
Off High info
70% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

SKIN is trading near its 52-week low of $9.68 (6.9% above the low).

Summary

Q3 net sales fell 2.1% to $69.2 million as delivery system placements dropped to 798 from 875, but consumables returned to growth at $50.4 million and adjusted EBITDA rose to $13.4 million from $8.9 million a year ago. Gross margin expanded to 68.2% from 64.6%, and the net loss narrowed to $0.9 million from $11.0 million, helped by lower operating spend. The company retired the remaining $103.2 million of its 2026 Notes on September 30, leaving roughly $112 million in cash. Management guided FY2026 to $281-$287 million in net sales and $48-$50 million in adjusted EBITDA, citing continued sales pressure offset by cost discipline. The 1-for-20 reverse split took effect October 14, so all per-share figures here are post-split. The earnings call is at 4:30 p.m. ET today.

At the time of this announcement, SKIN was trading at $10.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $67.3M. The 52-week trading range was $9.68 to $34.80. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

SKIN - Latest Insights

SKIN
Nov 05, 2026, 5:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.35
Real-time Price: $11.77 info
Change: +$1.42 (+14%) info
Market Cap: $77.005M info
SKIN
Nov 05, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.35
Real-time Price: $11.77 info
Change: +$1.42 (+14%) info
Market Cap: $77.005M info
SKIN
Oct 06, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.586
Real-time Price: $11.77 info
Change: Reverse Stock Split info
Market Cap: $77.005M info
SKIN
Aug 12, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.6468
Real-time Price: $11.77 info
Change: Reverse Stock Split info
Market Cap: $77.005M info
SKIN
Aug 06, 2026, 5:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.693
Real-time Price: $11.77 info
Change: Reverse Stock Split info
Market Cap: $77.005M info